Endocrine and Metabolic Characteristics and Prognosis of Long COVID Following SARS-CoV-2 Infection During the Omicron Period
Journal of Clinical Medicine · 01.11.2026 · 15 (21) · 8492
DOI: 10.3390/jcm15218492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.11.2026. Verfasst von Daisuke Omura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, AMED, Japanese Society of Hospital General Medicine.
Abstract (Originalsprache)
Background
The clinical features and recovery of patients with obesity and Long COVID remain incompletely understood.
Methods
We retrospectively analyzed 903 patients attending a COVID-19 aftercare clinic during the Omicron period. Biomarkers were compared across body mass index (BMI) categories. Recovery was defined as physician-determined conclusion of outpatient follow-up following sufficient symptom improvement, not necessarily complete resolution. Recovery analyses were exploratory; 572 patients comprised a sensitivity cohort clinically compatible with the World Health Organization (WHO) post-COVID-19 condition definition.
Results
Serum ferritin levels were higher in overweight and obese men than in normal-weight men. Cortisol/adrenocorticotropic hormone (ACTH) ratios in women and free thyroxine (FT4) levels in men differed across BMI categories. Recovery analysis from symptom onset included 565 participants and 186 events. Men with obesity had a lower recovery hazard than normal-weight men, with consistent direction across sensitivity analyses (age-adjusted pooled model, n = 565; hazard ratio: 0.390; 95% CI: 0.170–0.894), based on six recovery events among men with obesity. The main sex-by-obesity interaction was nonsignificant; additional interaction results varied by model. The WHO-compatible recovery analysis was limited by sparse events.
Conclusions
Obesity was associated with a longer time to clinically defined recovery among men, alongside BMI-related endocrine–metabolic differences. These exploratory findings warrant confirmation; sparse events and residual confounding preclude causal or definitive sex-specific conclusions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
ORCID-Profile: Daisuke Omura, Yoshiaki Soejima, Yuki Otsuka, Yasuhiro Nakano, Kazuki Tokumasu, Yasue Sakurada, Hiroyuki Honda, Fumio Otsuka
Förderung
- Japan Agency for Medical Research and Development
- AMED
- Japanese Society of Hospital General Medicine
- Ofuji Endocrine Medical Award
- Growth Science Foundation
- Kobayashi Magobe Memorial Medical Foundation
Zitieren
APA
Omura, D., Soejima, Y., Otsuka, Y., Nakano, Y., Tokumasu, K., Matsuda, Y., Sakurada, Y., Takase, R., Suyama, A., Kawaguchi, M., Hasegawa, T., Honda, H., Ueda, K., & Otsuka, F. (2026). Endocrine and Metabolic Characteristics and Prognosis of Long COVID Following SARS-CoV-2 Infection During the Omicron Period. Journal of Clinical Medicine, 15(21), 8492. https://doi.org/10.3390/jcm15218492
Vancouver
Omura D, Soejima Y, Otsuka Y, Nakano Y, Tokumasu K, Matsuda Y, et al. Endocrine and Metabolic Characteristics and Prognosis of Long COVID Following SARS-CoV-2 Infection During the Omicron Period. Journal of Clinical Medicine. 2026;15(21):8492. doi:10.3390/jcm15218492
BibTeX
@article{Omura2026,
author = {Omura, Daisuke and Soejima, Yoshiaki and Otsuka, Yuki and Nakano, Yasuhiro and Tokumasu, Kazuki and Matsuda, Yui and Sakurada, Yasue and Takase, Ryosuke and Suyama, Atsuhito and Kawaguchi, Marina and Hasegawa, Toru and Honda, Hiroyuki and Ueda, Keigo and Otsuka, Fumio},
title = {Endocrine and Metabolic Characteristics and Prognosis of Long COVID Following SARS-CoV-2 Infection During the Omicron Period},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8492},
doi = {10.3390/jcm15218492}
}
EUVIMED